ES2156899T3 - Nuevo procedimiento de preparacion de ergotioneina. - Google Patents

Nuevo procedimiento de preparacion de ergotioneina.

Info

Publication number
ES2156899T3
ES2156899T3 ES94920514T ES94920514T ES2156899T3 ES 2156899 T3 ES2156899 T3 ES 2156899T3 ES 94920514 T ES94920514 T ES 94920514T ES 94920514 T ES94920514 T ES 94920514T ES 2156899 T3 ES2156899 T3 ES 2156899T3
Authority
ES
Spain
Prior art keywords
ergotioneine
new
substitute
preparation procedure
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94920514T
Other languages
English (en)
Inventor
Jean-Claude Yadan
Jinzhu Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxis Isle of Man Ltd
Original Assignee
Oxis Isle of Man Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26230438&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2156899(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9307839A external-priority patent/FR2707086A1/fr
Application filed by Oxis Isle of Man Ltd filed Critical Oxis Isle of Man Ltd
Application granted granted Critical
Publication of ES2156899T3 publication Critical patent/ES2156899T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A UN NUEVO PROCESO DE PREPARACION DE ERGOTIONEINA. EL PROCESO DE SINTESIS QUIMICA DE LAS DIFERENTES FORMAS OPTICAS DE LA ERGOTIONEINA SE CARACTERIZA EN QUE COMPRENDE ESENCIALMENTE LAS ETAPAS QUE CONSISTEN EN PREPARAR O UTILIZAR UNA SAL DE ESTER DE HISTIDINANALFAR-NALFA-DIMETILADA, SI ES NECESARIO OPTICAMENTE ACTIVO; EN TRATAR ESTE COMPUESTO, POR UN HALOGENOTIONOFORMIATO DE ALKILO, DE ALQUENILO O DE ARILO, EN PRESENCIA DE UNA BASE; Y TRAS LA PROTECCION DEL SUSTITUYENTE AZUFRADO DEL COMPUESTO OBTENIDO, TRANSFORMAR ESTE ULTIMO EN UN COMPUESTO DE TIPO TRIMETILAMONIO, Y EN LIBERAR LA ERGOTIONEINA DESEADA POR SAPONIFICACION O HIDROLISIS ACIDA, SEGUN EL CASO. ESTE PROCESO PROCURA UN MEJOR RENDIMIENTO Y ASEGURA UNA EXCELENTE PUREZA OPTICA.
ES94920514T 1993-06-28 1994-06-27 Nuevo procedimiento de preparacion de ergotioneina. Expired - Lifetime ES2156899T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9307839A FR2707086A1 (fr) 1993-06-28 1993-06-28 Procédé de préparation de l'ergothionéine.
FR9315457A FR2707087B1 (fr) 1993-06-28 1993-12-22 Nouveau procédé de préparation de l'ergothionéine.

Publications (1)

Publication Number Publication Date
ES2156899T3 true ES2156899T3 (es) 2001-08-01

Family

ID=26230438

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94920514T Expired - Lifetime ES2156899T3 (es) 1993-06-28 1994-06-27 Nuevo procedimiento de preparacion de ergotioneina.

Country Status (9)

Country Link
US (1) US5438151A (es)
EP (1) EP0656890B1 (es)
JP (2) JP3840616B2 (es)
AU (1) AU688337B2 (es)
CA (1) CA2143419C (es)
DE (1) DE69426520T2 (es)
ES (1) ES2156899T3 (es)
FR (1) FR2707087B1 (es)
WO (1) WO1995000494A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707087B1 (fr) * 1993-06-28 1995-10-13 Bioxytech Nouveau procédé de préparation de l'ergothionéine.
US6479533B1 (en) 1997-02-20 2002-11-12 Applied Genetics Incorporated Dermatics Methods and compositions for the protection of mitochondria
US6103746A (en) * 1997-02-20 2000-08-15 Oxis International, Inc. Methods and compositions for the protection of mitochondria
AU2474399A (en) 1998-01-26 1999-08-09 Mitokor Mitochondria protecting agents for treating mitochondria associated diseases
WO1999040926A1 (en) * 1998-02-13 1999-08-19 Nutramax Laboratories, Inc. Agents and methods for protection, treatment and repair of connective tissue
FR2810548A1 (fr) * 2000-06-26 2001-12-28 Oreal Utilisation d'ergothioneine et/ou de ses derives comme agent anti-glycation
US20050042233A1 (en) * 2003-08-21 2005-02-24 Christopher Marrs Stabilized compositions containing an oxygen-labile active agent and a fungal extract
US20050042306A1 (en) * 2003-08-21 2005-02-24 Christopher Marrs Stabilized compositions containing an oxygen-labile active agent
FR2910808B1 (fr) * 2006-12-29 2009-04-10 Lvmh Rech Utilisation en cosmetique de la l-2-thiohistidine ou d'un de ses derives comme agent depigmentant.
US20100076093A1 (en) * 2007-03-07 2010-03-25 Beelman Robert B Use of ergothioneine as a preservative in foods and beverages
US7767826B2 (en) * 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
US8933245B2 (en) 2009-01-30 2015-01-13 Elc Management Llc Preservation of ergothioneine
US8410156B2 (en) * 2009-01-30 2013-04-02 Elc Management, Llc Preservation of ergothioneine
FR2950890B1 (fr) * 2009-10-06 2011-12-30 Tetrahedron Procede de synthese de la 2-thiohistidine et analogues
FR2950889B1 (fr) 2009-10-06 2011-11-18 Tetrahedron Procede de synthese de l'ergothioneine et analogues
US10544437B2 (en) 2014-04-29 2020-01-28 Conagen Inc. Microbial ergothioneine biosynthesis
WO2016104437A1 (ja) 2014-12-22 2016-06-30 国立大学法人 岡山大学 エルゴチオネインの産生方法
EP3268354B1 (en) 2015-03-13 2020-05-06 Mironova Innovations, LLC Nalpha, nalpha, nalpha-trialkyl histidine derivatives useful for the preparation of ergothioneine compounds
WO2019163767A1 (ja) 2018-02-23 2019-08-29 長瀬産業株式会社 エルゴチオネインの製造方法
CA3145979A1 (en) 2019-07-10 2021-01-14 Kureha Corporation Plant growth regulator and method for promoting plant growth
US20230091310A1 (en) 2019-12-27 2023-03-23 National Center For Child Health And Development Inhibitor of Fertilized Egg Fragmentation
US20240141396A1 (en) 2021-03-01 2024-05-02 Nagase & Co., Ltd. Ergothioneine production method
WO2022220123A1 (ja) * 2021-04-14 2022-10-20 長瀬産業株式会社 Ｌ－エルゴチオネイン含有組成物
WO2023234307A1 (ja) 2022-05-31 2023-12-07 キッコーマン株式会社 エルゴチオネイン生産性を高めるように改変された核酸、並びに遺伝子改変された微生物
CN119365076A (zh) 2022-07-06 2025-01-24 株式会社吴羽 植物生长调整剂、植物的生长促进方法或植物生长调整用产品
AR130564A1 (es) 2022-09-27 2024-12-18 Kureha Corp Agente para mejorar la tolerancia al estrés ambiental en una planta y método para mejorar la tolerancia al estrés ambiental en una planta
AR134099A1 (es) 2023-10-16 2025-12-03 Kureha Corp Método para tratar una planta, formulación, propágulo de una planta, método para cultivar una planta, y plántula de trasplante
AR134410A1 (es) 2023-11-21 2026-01-14 Kureha Corp Agente para mejorar la recuperabilidad de daño y formulación para mejorar la recuperabilidad de daño de la planta, método para mejorar la recuperabilidad de daño de la planta, cuerpo de la planta y agente para mejorar la tolerancia al estrés físico de la planta
AR134409A1 (es) 2023-11-21 2026-01-14 Kureha Corp Mejorador de tolerancia al estrés abiótico de una planta, método para mejorar la tolerancia al estrés abiótico, formulación para mejorar la tolerancia al estrés abiótico, producto para mejorar la tolerancia al estrés abiótico, y planta
WO2025143153A1 (ja) * 2023-12-27 2025-07-03 株式会社クレハ 植物の生育期間短縮化剤および生育期間短縮用の製剤、花成誘導遺伝子の発現誘導剤、植物の生育期間を短縮化させる方法、植物体、植物の生育速度の均一化剤、ならびに植物の生育速度を均一化させる方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707087B1 (fr) * 1993-06-28 1995-10-13 Bioxytech Nouveau procédé de préparation de l'ergothionéine.

Also Published As

Publication number Publication date
CA2143419C (en) 2006-01-24
JPH08501575A (ja) 1996-02-20
EP0656890A1 (fr) 1995-06-14
WO1995000494A1 (fr) 1995-01-05
JP3840616B2 (ja) 2006-11-01
CA2143419A1 (en) 1995-01-05
FR2707087B1 (fr) 1995-10-13
DE69426520T2 (de) 2001-07-12
EP0656890B1 (fr) 2001-01-03
FR2707087A1 (fr) 1995-01-06
AU688337B2 (en) 1998-03-12
AU7127694A (en) 1995-01-17
DE69426520D1 (de) 2001-02-08
US5438151A (en) 1995-08-01
JP2006160748A (ja) 2006-06-22

Similar Documents

Publication Publication Date Title
AR004122A1 (es) Procedimiento para la preparacion de un compuesto de dihaloazolopirimidinas y un procedimiento para la preparacion de un intermediario de dicho procedimiento
AR046567A1 (es) Procesos de preparacion de esteres de acidos mono, di o policarboxilicos
CL2004000969A1 (es) Compuestos derivados de alquilarilo; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y/o profilaxis de la obesidad y trastornos relacionados.
SE0301368D0 (sv) Chemical compounds
BR0211020A (pt) Processo para a produção de um poliéster
DE69220773D1 (de) Verfahren zur Herstellung von Detergenskörnchen durch Neutralisation von Sulfonsäuren
ATE310009T1 (de) Reaktionssysteme zur herstellung von n- (phosphonomethyl)glyzin verbindungen
ATE86978T1 (de) Verfahren zur herstellung von 3,5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer.
IT1273512B (it) Composizione acida cristallina mesoporosa di un difosfonato-fosfito di un metallo tetravalente utile come catalizzatore
DE60229194D1 (de) Verfahren zur Herstellung von Acrylsäure
ATE284405T1 (de) Neues verfahren zur herstellung von oxabispidinen
BR0114739A (pt) Processo para a preparação de uma solução de um polìmero contendo unidades azol repetidas, soluções preparadas por este processo e sua aplicação
SE0300957D0 (sv) Chemical compounds
ATE159283T1 (de) Verfahren zur herstellung von konzentrierten, magnesium enthaltenden tensidmischungen
DE502004007479D1 (de) Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-phosphaphenanthren-10-oxid und Derivaten desselben
DE50104094D1 (de) Verfahren zur Herstellung von reinem Triethylendiamin (TEDA)
ATE265416T1 (de) Kontinuierliches adiabatisches verfahren zur herstellung von nitrochlorbenzol
BR0315254A (pt) Processo para a fabricação de um composto, e, composto
DK0687256T3 (da) Hydroxymethylfurazancarboxylsyrederivater og deresanvendelse ved behandling af kardiovaskulære sygdomme
ES2032582T3 (es) Procedimiento para preparar derivados de la oxima del 1,2,5,6,-tetrahidropiridin -3-carboxialdehido.
BR0206964A (pt) Diamidas de ácido ftálico, um processo para a sua preparação e sua aplicação como composições praguicidas
ATE130845T1 (de) Verfahren zur herstellung von 3-amino-2- (het)aroyl-acrylsäurederivaten.
ES2089654T3 (es) Procedimiento para purificar amidas de acidos grasos.
DE60216117T8 (de) Verfahren zur herstellung von hexafluoraceton und dessen hydrat
ES2169399T3 (es) Procedimiento para preparar heterociclos de fenilo utiles como inhibidores de la cox-2.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 656890

Country of ref document: ES